BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22629824)

  • 1. [Prognosis for the metastasis of squamous cell carcinoma of the head and neck].
    Kakurina GV; Kondakova IV; Choĭnzonov EL
    Vopr Onkol; 2012; 58(1):26-32. PubMed ID: 22629824
    [No Abstract]   [Full Text] [Related]  

  • 2. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 3. Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers.
    Takes RP
    Oral Oncol; 2004 Aug; 40(7):656-67. PubMed ID: 15172634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular assay to detect metastatic head and neck squamous cell carcinoma.
    Becker MT; Shores CG; Yu KK; Yarbrough WG
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):21-7. PubMed ID: 14732763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients?
    Ralhan R
    Expert Rev Proteomics; 2012 Apr; 9(2):115-8. PubMed ID: 22462781
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
    Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
    Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
    Eibling DE; Johnson JT; Wagner RL; Su S
    Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.
    Gross ND; Ellingson TW; Wax MK; Cohen JI; Andersen PE
    Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):169-73. PubMed ID: 14967745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in squamous cell carcinomas of the head and neck.
    Liu M; Weynand B; Delos M; Marbaix E
    Acta Otorhinolaryngol Belg; 1999; 53(3):155-60. PubMed ID: 10635383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mediators of metastasis in head and neck squamous cell carcinoma.
    Howell GM; Grandis JR
    Head Neck; 2005 Aug; 27(8):710-7. PubMed ID: 15952195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-erbB-2 expression in squamous cell carcinoma of the head and neck.
    Field JK; Spandidos DA; Yiagnisis M; Gosney JR; Papadimitriou K; Stell PM
    Anticancer Res; 1992; 12(3):613-9. PubMed ID: 1377893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of patients with metastatic cancer of unknown primary.
    Ghosh L; Dahut W; Kakar S; Posadas EM; Torres CG; Cancel-Santiago R; Ghosh BC
    Curr Probl Surg; 2005 Jan; 42(1):12-66. PubMed ID: 15711508
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
    Mannello F
    Cancer; 2003 Jan; 97(1):201-3; author reply 203-4. PubMed ID: 12491521
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of molecular markers in the management of head and neck cancers.
    Ferreira MB; De Souza JA; Cohen EE
    Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-erbB-2 gene in human head and neck carcinoma.
    Craven JM; Pavelic ZP; Stambrook PJ; Pavelic L; Gapany M; Kelley DJ; Gapany S; Gluckman JL
    Anticancer Res; 1992; 12(6B):2273-6. PubMed ID: 1363518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck.
    Palme CE; MacKay SG; Kalnins I; Morgan GJ; Veness MJ
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):103-6. PubMed ID: 17413411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung.
    Mercer RR; Lucas NC; Simmons AN; Zander DS; Tsongalis GJ; Funkhouser WK; Coleman WB
    Exp Mol Pathol; 2009 Feb; 86(1):1-9. PubMed ID: 19094981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of inducible nitric oxide synthase mRNA in squamous cell carcinoma of tongue].
    Chen WL; Zeng SG; Li HG; Huang HZ; Pan CB
    Ai Zheng; 2002 Mar; 21(3):314-8. PubMed ID: 12452003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.